Get the Stockscreener App
35.02
5.51%
1.83
After Hours:
34.55
-0.47
-1.34%
Metsera Inc stock is traded at $35.02, with a volume of 2.36M.
It is up +5.51% in the last 24 hours and down -13.47% over the past month.
Metsera Inc is a clinical-stage biotechnology company developing next-generation injectable and oral nutrient-stimulated hormone (NuSH) analog peptides to treat obesity, overweight, and related conditions. The Company has developed and is implementing proprietary methods and platform technologies to advance a broad, scalable, and combinable portfolio of injectable and oral NuSH analog peptides with the potential to address not only the limitations of approved therapies but also many of the anticipated limitations of next-generation therapies in development. The Company uses its proprietary MINT peptide library of NuSH analog peptides alongside its Half-life Augmentation by Lipid Optimization half-life extending platform.
See More
Previous Close:
$33.19
Open:
$33.9
24h Volume:
2.36M
Relative Volume:
2.10
Market Cap:
$3.68B
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+8.79%
1M Performance:
-13.47%
6M Performance:
+40.02%
1Y Performance:
+0.00%
1-Day Range:
$33.70
$35.79
1-Week Range:
$30.81
$35.79
52-Week Range:
$12.30
$47.40
Metsera Inc Stock (MTSR) Company Profile
Name
Metsera Inc
Sector
Industry
Phone
(212) 784-6595
Address
3 WORLD TRADE CENTER, NEW YORK
Compare MTSR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MTSR
Metsera Inc
|
35.02 | 3.49B | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
389.08 | 99.27B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
586.96 | 62.28B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.18 | 59.14B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
707.96 | 43.34B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
300.14 | 36.72B | 3.81B | -644.79M | -669.77M | -6.24 |
Metsera Inc Stock (MTSR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-20-25 | Initiated | Wells Fargo | Overweight |
| Feb-25-25 | Initiated | BofA Securities | Buy |
| Feb-25-25 | Initiated | Evercore ISI | Outperform |
| Feb-25-25 | Initiated | Guggenheim | Buy |
Metsera Inc Stock (MTSR) Latest News
Metsera to Present at Upcoming September Investor Conferences - GlobeNewswire
How to read the order book for Metsera Inc.Weekly Market Report & Verified Stock Trade Ideas - Newser
Should you wait for a breakout in Metsera Inc.Market Trend Report & Risk Adjusted Buy/Sell Alerts - Newser
Statistical indicators supporting Metsera Inc.’s strengthQuarterly Performance Summary & Verified Chart Pattern Trade Signals - Newser
Is Metsera Inc. meeting your algorithmic filter criteriaInflation Watch & Free Expert Verified Stock Movement Alerts - Newser
How high can Metsera Inc. stock goWeekly Market Report & Free High Return Stock Watch Alerts - Newser
Metsera, Inc. Shares Surge Amid Positive Outlook - TipRanks
Market reaction to Metsera Inc.’s recent newsJuly 2025 News Drivers & Expert Verified Stock Movement Alerts - Newser
Analyzing drawdowns of Metsera Inc. with statistical toolsJuly 2025 Review & Safe Capital Investment Plans - Newser
Understanding Metsera Inc.’s price movementJuly 2025 Market Mood & Precise Swing Trade Entry Alerts - Newser
5 Biotech Stocks To Watch Ahead Of Major Clinical Trial Data Readouts In September 2025 - RTTNews
Is Metsera Inc. showing signs of accumulationJuly 2025 Patterns & Free Community Consensus Stock Picks - Newser
Regression analysis insights on Metsera Inc. performancePortfolio Return Summary & Fast Gain Stock Trading Tips - Newser
Smart Money: Is Metsera Inc. affected by consumer sentiment2025 Technical Patterns & AI Powered Market Entry Strategies - sundaytimes.kr
How to interpret RSI for Metsera Inc. stockPortfolio Performance Report & Long-Term Investment Growth Plans - Newser
Chart based analysis of Metsera Inc. trendsTrade Volume Summary & Reliable Volume Spike Trade Alerts - Newser
Analyzing net buyer seller activity in Metsera Inc.Weekly Stock Recap & Accurate Entry/Exit Alerts - Newser
Is Metsera Inc. trending in predictive chart modelsJuly 2025 Snapshot & Daily Profit Focused Screening - Newser
Sentiment Watch: Is Metsera Inc. on track to beat earningsJuly 2025 Momentum & Capital Protection Trade Alerts - theviewers.co.kr
What is Metsera Inc. s 5 year growth outlookWeekly Stock Report & Daily Market Momentum Tracking - theviewers.co.kr
Metsera’s (MTSR) Amylin Agonist Data Leads to Price Target Increase - Insider Monkey
Metsera Inc. Stages Intraday Comeback — Trend Change2025 Technical Patterns & Community Consensus Trade Signals - beatles.ru
Biopharma IPO drought continues: chance of rain expected? - BioWorld MedTech
Metsera, Inc. shares fall 4.48% intraday due to broader biotech sector decline and poor Q2 earnings report. - AInvest
Published on: 2025-08-19 03:03:18 - Newser
What makes Metsera Inc. stock price move sharplyJuly 2025 Levels & Weekly High Momentum Picks - Newser
Technical analysis overview for Metsera Inc. stockTrade Volume Report & Free Weekly Chart Analysis and Trade Guides - Newser
Comparing Metsera Inc. in custom built stock radarsMarket Risk Report & Weekly High Return Stock Opportunities - Newser
Short interest data insights for Metsera Inc.Share Buyback & Safe Entry Point Alerts - Newser
Measuring Metsera Inc.’s beta against major indicesMarket Trend Summary & Consistent Profit Trade Alerts - Newser
Custom watchlist performance reports with Metsera Inc.2025 Historical Comparison & Real-Time Stock Entry Alerts - Newser
Why Metsera Inc. stock attracts strong analyst attentionEarnings Miss & Verified Short-Term Plans - thegnnews.com
Price Action Confirms Reversal in Metsera Inc. TrendJuly 2025 Final Week & Reliable Intraday Trade Plans - newsyoung.net
SoftBank Group's Q2 Portfolio Changes: New Stakes in Metsera and eToro, Reduced Lemonade Holding - AInvest
SoftBank adds new Metsera, eToro stakes, pares Lemonade holding, among Q2 trades (SFTBF:Pink Limited Info) - Seeking Alpha
Sector Leaders Rotate Capital Into Metsera Inc.2025 Valuation Update & AI Powered Trade Plan Recommendations - beatles.ru
Metsera Inc Stock (MTSR) Financials Data
There is no financial data for Metsera Inc (MTSR). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.98%
8.06%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):